Cardiology Journal Articles

• The Impact of Revascularization on Mortality A new analysis highlights the differences between registries and RCTs when it comes to evaluating the impact of revascularization on the interplay between LVEF, myocardial ischemia, and mortality.
  Journal of the American College of Cardiology, October 10, 2022
• Complementary Pharmacotherapy for STEMI Undergoing PCI This review provides an evidence-based update to complementary pharmacotherapy for STEMI patients undergoing primary PCI.
  American Journal of Cardiovascular Drugs, October 06, 2022
• Ischemic Heart Disease Risk and Remnant Cholesterol Levels A new study suggests that non-fasting remnant cholesterol can provide useful information for atherosclerotic cardiovascular disease risk estimation.
  Journal of the American College of Cardiology, October 03, 2022
• Cerebral Venous Sinus Thrombosis in Patients With COVID-19 While cerebral venous sinus thrombosis is rare in the non-COVID general population, this study found a high incidence in patients hospitalized with COVID-19.
  Stroke, September 27, 2022
• The TAVR Subclinical Leaflet Thrombosis Puzzle Two recent studies address some important missing aspects of the puzzle of subclinical leaflet thrombosis, which is present in up to 10% to 15% of patients after TAVR---but questions still remain.
  Circulation, September 26, 2022
• Autonomic Dysfunction in Post-Acute Sequela of COVID-19 This evaluation of head-up tilt table results in patients with long COVID revealed orthostatic intolerance in nearly all subjects, suggestive of autonomic dysfunction.
  Journal of the American College of Cardiology, September 26, 2022
• Should Polypills Be Used for HFrEF? The authors propose a polypill strategy, comprising low doses of multiple generic medications taken once daily, to enable convenient initiation of therapy in patients newly diagnosed with HFrEF.
  Circulation, September 16, 2022
• Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes This analysis examined the effects of subcutaneous or oral semaglutide, versus placebo, on stroke and its subtypes in people with type 2 diabetes at high cardiovascular risk.
  Stroke, September 13, 2022
• HFrEF: "The Importance of Being Frail" A new study reveals that that frail patients with HFrEF realize greater benefits from exercise training than nonfrail patients.
  Circulation, September 02, 2022
• Stroke of Other Determined Etiology Review the different characteristics, demographic findings, lesion locations, and outcomes of uncommon causes of stroke and their subtypes.
  Stroke, August 30, 2022
• At the Crossroad Between Skeletal and Cardiac Muscle Cells A new study elucidates the association between elevated circulating cardiac troponin levels and various myopathies. What are the clinical implications for elevated cTn as a biomarker in CVD?
  Circulation, August 26, 2022
• Treating Acute Stroke in the Platinum 30 Minutes This study aimed to characterize the frequency, characteristics, and outcomes of acute stroke patients treated in the "platinum half hour"--that is, within 30 minutes from initial onset.
  Stroke, August 16, 2022
• Evidence Builds for Catheter Ablation for AF and Heart Failure This article summarizes recent clinical trials which provide a growing body of evidence on the benefits of catheter ablation in the management of AF in patients with concomitant heart failure.
  Circulation, August 12, 2022
• Endothelial Cells, Platelets in COVID Cerebrovascular Events Recent research has helped further our understanding of the involvement of endothelial cells and platelets in the development of COVID-19 related cerebrovascular events.
  Stroke, August 03, 2022
• Managing Methamphetamine Associated Cardiomyopathy Methamphetamine-associated cardiomyopathy is a serious but reversible complication of illicit methamphetamine use. Review its pathophysiology and a holistic approach to management in this paper.
  American Journal of Cardiovascular Drugs, August 01, 2022
• Is Endovascular Thrombectomy for the Very Elderly? Endovascular thrombectomy is considered an effective treatment for acute stroke, but should this procedure be considered for very elderly patients? This editorial explores the issue.
  Stroke, July 20, 2022
• Detecting Coronary Calcium in Young Adults: Are We There Yet? Should young adults aged 30-45 years be considered for assessment of coronary artery calcium, and if so, who?
  Journal of the American College of Cardiology, July 12, 2022
• Updated Heart Failure Guidelines: Time for a Refresh Two prestigious new clinical guidelines differ in their approach to treatment of heart failure. What factors could account for the different recommendations, and how can they be reconciled?
  Circulation, July 08, 2022
• Optimizing Blood Pressure Components for a Healthy Brain A recent study highlights the impact of specific blood pressure components on cognitive decline and incident dementia, with a focus on the importance of pulse pressure.
  Journal of the American College of Cardiology, July 05, 2022
• CVT in Patients With Heparin-Induced Thrombocytopenia Cerebral venous thrombosis, an uncommon but severe thrombotic manifestation of heparin-induced thrombocytopenia, has also been reported in patients receiving an adenovirus-based SARS-CoV-2 vaccine.
  Stroke, June 29, 2022